申请人:Morinaga Milk Industry Co., Ltd.
公开号:US05589506A1
公开(公告)日:1996-12-31
The present invention relates to a novel compound having a 12-lipoxygenase inhibitory effect, of the general formula (I), a precursor thereof, and a medicine containing the same, ##STR1## wherein R.sup.1 represents a hydrogen atom or a hydroxy group; one of R.sup.2 and R.sup.3 represents a hydrogen atom, while the other cyano group ; and Ar is a group represented by the following general formula (a), (b) or (c), ##STR2## wherein R.sup.4 represents a hydrogen atom, a lower alkyl group, a lower alkoxy group, a halogen atom, a thrifluoromethyl group or a cyano group.
本发明涉及一种具有12-脂氧合酶抑制作用的新化合物,其一般式(I),其前体以及含有该化合物的药物,其中R.sup.1代表氢原子或羟基;R.sup.2和R.sup.3中的一个代表氢原子,另一个代表氰基;Ar是由以下一般式(a),(b)或(c)表示的基团,其中R.sup.4代表氢原子,较低的烷基基团,较低的烷氧基团,卤原子,三氟甲基基团或氰基。